Cargando…
Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction
BACKGROUND & AIMS: We aimed to evaluate long-term outcome of patients with chronic non-cirrhotic extrahepatic portal vein obstruction (CNC-EHPVO) who underwent portal vein recanalisation (PVR) without transjugular intrahepatic portosystemic shunt (TIPS) insertion and to determine factors predict...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253474/ https://www.ncbi.nlm.nih.gov/pubmed/35801087 http://dx.doi.org/10.1016/j.jhepr.2022.100511 |
_version_ | 1784740494607122432 |
---|---|
author | Artru, Florent Vietti-Violi, Naik Sempoux, Christine Vieira Barbosa, Joana Becce, Fabio Sah, Nelly Marot, Astrid Deltenre, Pierre Moschouri, Eleni Fraga, Montserrat Hocquelet, Arnaud Duran, Rafael Moradpour, Darius Rautou, Pierre-Emmanuel Denys, Alban |
author_facet | Artru, Florent Vietti-Violi, Naik Sempoux, Christine Vieira Barbosa, Joana Becce, Fabio Sah, Nelly Marot, Astrid Deltenre, Pierre Moschouri, Eleni Fraga, Montserrat Hocquelet, Arnaud Duran, Rafael Moradpour, Darius Rautou, Pierre-Emmanuel Denys, Alban |
author_sort | Artru, Florent |
collection | PubMed |
description | BACKGROUND & AIMS: We aimed to evaluate long-term outcome of patients with chronic non-cirrhotic extrahepatic portal vein obstruction (CNC-EHPVO) who underwent portal vein recanalisation (PVR) without transjugular intrahepatic portosystemic shunt (TIPS) insertion and to determine factors predicting PVR failure and stent occlusion. METHODS: This retrospective monocentric study included all patients who underwent PVR without TIPS insertion in the context of CNC-EHPVO between the years 2000 and 2019. Primary patency was defined by the absence of a complete stent occlusion on follow-up imaging. RESULTS: A total of 31 patients underwent PVR with a median follow-up of 52 months (24–82 months). Indications were gastrointestinal bleeding (n = 13), abdominal pain attributed to CNC-EHPVO (n = 7), prior to abdominal surgery (n = 4), and others (n = 7). Technical success was obtained in 27 patients. PVR failure was associated with extension within the intrahepatic portal veins (p = 0.005) and recanalisation for abdominal pain (p = 0.02). Adverse events occurred in 6 patients with no mortality. Anticoagulation was administered in 21 patients after technical success of PVR. In patients with technical success, 5-year primary patency was 73% and was associated with improved muscle mass (p = 0.007) and decreased spleen volume (p = 0.01) at 1 year. Furthermore, 21 (78%) patients with PVR technical success were free of portal hypertension complication at 5 years. CONCLUSIONS: PVR without TIPS insertion was feasible and safe in selected patients with CNC-EHPVO and portal hypertension with past or expected complications. Primary patency at 5 years was obtained in 3 of 4 patients with technical success of PVR and was associated with a control of complications of CNC-EHPVO. PVR was associated with improvement of sarcopenia and decreased spleen volume at 1 year. LAY SUMMARY: Patients with chronic obstruction of the portal vein and without cirrhosis or malignancy can develop complications related to the high pressure in the venous system. The present study reports long-term favourable outcome of patients in whom the obstruction was treated with stents. |
format | Online Article Text |
id | pubmed-9253474 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-92534742022-07-06 Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction Artru, Florent Vietti-Violi, Naik Sempoux, Christine Vieira Barbosa, Joana Becce, Fabio Sah, Nelly Marot, Astrid Deltenre, Pierre Moschouri, Eleni Fraga, Montserrat Hocquelet, Arnaud Duran, Rafael Moradpour, Darius Rautou, Pierre-Emmanuel Denys, Alban JHEP Rep Research Article BACKGROUND & AIMS: We aimed to evaluate long-term outcome of patients with chronic non-cirrhotic extrahepatic portal vein obstruction (CNC-EHPVO) who underwent portal vein recanalisation (PVR) without transjugular intrahepatic portosystemic shunt (TIPS) insertion and to determine factors predicting PVR failure and stent occlusion. METHODS: This retrospective monocentric study included all patients who underwent PVR without TIPS insertion in the context of CNC-EHPVO between the years 2000 and 2019. Primary patency was defined by the absence of a complete stent occlusion on follow-up imaging. RESULTS: A total of 31 patients underwent PVR with a median follow-up of 52 months (24–82 months). Indications were gastrointestinal bleeding (n = 13), abdominal pain attributed to CNC-EHPVO (n = 7), prior to abdominal surgery (n = 4), and others (n = 7). Technical success was obtained in 27 patients. PVR failure was associated with extension within the intrahepatic portal veins (p = 0.005) and recanalisation for abdominal pain (p = 0.02). Adverse events occurred in 6 patients with no mortality. Anticoagulation was administered in 21 patients after technical success of PVR. In patients with technical success, 5-year primary patency was 73% and was associated with improved muscle mass (p = 0.007) and decreased spleen volume (p = 0.01) at 1 year. Furthermore, 21 (78%) patients with PVR technical success were free of portal hypertension complication at 5 years. CONCLUSIONS: PVR without TIPS insertion was feasible and safe in selected patients with CNC-EHPVO and portal hypertension with past or expected complications. Primary patency at 5 years was obtained in 3 of 4 patients with technical success of PVR and was associated with a control of complications of CNC-EHPVO. PVR was associated with improvement of sarcopenia and decreased spleen volume at 1 year. LAY SUMMARY: Patients with chronic obstruction of the portal vein and without cirrhosis or malignancy can develop complications related to the high pressure in the venous system. The present study reports long-term favourable outcome of patients in whom the obstruction was treated with stents. Elsevier 2022-05-25 /pmc/articles/PMC9253474/ /pubmed/35801087 http://dx.doi.org/10.1016/j.jhepr.2022.100511 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Artru, Florent Vietti-Violi, Naik Sempoux, Christine Vieira Barbosa, Joana Becce, Fabio Sah, Nelly Marot, Astrid Deltenre, Pierre Moschouri, Eleni Fraga, Montserrat Hocquelet, Arnaud Duran, Rafael Moradpour, Darius Rautou, Pierre-Emmanuel Denys, Alban Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction |
title | Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction |
title_full | Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction |
title_fullStr | Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction |
title_full_unstemmed | Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction |
title_short | Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction |
title_sort | portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253474/ https://www.ncbi.nlm.nih.gov/pubmed/35801087 http://dx.doi.org/10.1016/j.jhepr.2022.100511 |
work_keys_str_mv | AT artruflorent portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT viettiviolinaik portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT sempouxchristine portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT vieirabarbosajoana portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT beccefabio portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT sahnelly portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT marotastrid portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT deltenrepierre portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT moschourieleni portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT fragamontserrat portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT hocqueletarnaud portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT duranrafael portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT moradpourdarius portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT rautoupierreemmanuel portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction AT denysalban portalveinrecanalisationalonetotreatsevereportalhypertensioninnoncirrhoticpatientswithchronicextrahepaticportalveinobstruction |